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Breast can cer is the most fre quent ma lig nant neo plasm af fect ing the fe male pop u la tion. In or -
der to re duce its mor bid ity and mor tal ity rate, a mam mog ra phy screen ing cam paign has been
es tab lished in both en ti ties of Bosnia and Herzegovina. In this pa per, a brief sur vey is given on
the mam mog ra phy screen ing prac tice in the Republic of Srpska. As an il lus tra tion, re sults of
mea sure ments of tech ni cal pa ram e ters, in clud ing mean glan du lar dose, for 31 mam mog ra -
phy units are pre sented. Large fluc tu a tions in dose among dif fer ent mea sur ing sites were
found, un ac cept able not only from the stand point of mam mog ra phy screen ing, but in clin i cal
mam mog ra phy as a whole. Sub se quently, a se ries of qual ity con trol tests and cor rec tive mea -
sures through out the mam mog ra phy im ag ing chain are pro posed, in line with in ter na tional
guide lines and newly pro mul gated na tional leg is la tion. Dose op ti mi sa tion and im age qual ity
im prove ment are the first and fore most goals to be achieved in or der to setup a suc cess ful
mam mog ra phy screen ing pro gram.
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IN TRO DUC TION
Breast can cer is the most fre quent ma lig nant
solid tu mour af fect ing the fe male pop u la tion and one
of the most fre quent causes of can cer-in duced deaths
in women.
Mam mog ra phy is the only method of de tect ing
small le sions – masses and microcalcifications –
which are nei ther pal pa ble nor de tect able by any other
di ag nos tic method [1]. Ac cord ing to the meth od ol ogy
and pa tient tar get group, the clas si fi ca tion is turned in
early clin i cal de tec tion and mam mog ra phy screen ing.
Clin i cal mam mog ra phy is used in the di ag nos tics of
am big u ous clin i cal find ings in symp tom atic pa tients,
while early de tec tion rep re sents a di ag nos tic strat egy
for iden ti fy ing clin i cally oc cult breast can cer at an
early stage. Un like the first two meth ods, mam mog ra -
phy screen ing is used in asymp tom atic women [2].
Mam mog ra phy screen ing may be de fined as
mammographic im ag ing of a coun try’s over all fe male
pop u la tion within a cer tain de fined age group, with the 
goal of early-stage breast can cer de tec tion. Plain 2D
mam mog ra phy is the prin ci pal screen ing method of
choice be cause of its high spa tial res o lu tion (~0.1 mm) 
and, thus, the detectability of the can cer at an early
stage [2]. The mammogram is ac quired in two views
per breast – craniocaudal (CC) and mediolateral
oblique (MLO). The whole of the breast tis sue, as well
as some of the sur round ing tis sues, have to be im aged.
Im age ac qui si tion is pre ceded by breast com pres sion
which con trib utes to better im age qual ity as it pro -
duces con trast en hance ment and re duces blur ring
artefacts due to pa tient mo tion. Tis sue struc tures get
ex tended, re duc ing the dis tance be tween the tis sue and 
im age re cep tor, and pre vent the an a tomic struc tures
from over lap ping on a 2D-im age. A fur ther im por tant
ef fect of breast com pres sion is the re duc tion of the
dose to the breast be cause a smaller vol ume is ex posed
to X-rays. Com pressed breast thick ness is be tween 2
and 8 cm, whereas the area of the breast that is be ing
im aged may vary be tween 35-250 cm2 for each view
[3].
Mam mog ra phy also in volves ion is ing ra di a tion.
Thus, there is a cer tain risk for in duc ing can cer, since
the breast is a highly vul ner a ble radiosensitive or gan,
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par tic u larly in its de vel op ing phase, i. e. from ad o les -
cence to the be gin ning of the lac ta tion pe riod. Ac cord -
ing to some UK risk es ti mates, mam mog ra phy con -
trib utes with a 1:100000 can cer risk per each view,
with 1:21 be ing the over all risk of get ting breast can -
cer in the course of a life time [4]. 
MAM MOG RA PHY SCREEN ING IN THE
RE PUB LIC OF SRPSKA
De spite the fact that Bosnia and Herzegovina
now has a uni fied leg is la tion on ion is ing ra di a tion pro -
tec tion, as well as some healthcare strat e gies com mon
to both en ti ties, screen ing mam mog ra phy is per -
formed sep a rately in the Re pub lic of Srpska and the
Fed er a tion of Bosnia and Herzegovina. Min is try of
Healthcare of the Re pub lic of Srpska has re cently
launched a mam mog ra phy screen ing cam paign, spon -
sored by the Re pub lic of Srpska Health In sur ance
Fund. Screen ing prac tices took place at the Banja
Luka Clin i cal Cen tre, as well as sev eral other pub lic
and pri vate healthcare in sti tu tions equipped for the
task. Mean while, some multidisciplinary coun sel ling
bod ies were founded with the aim of pro vid ing a
means for more ef fi cient breast can cer as sess ment and
treat ment, but their ac tiv ity is not to be at trib uted to
mam mog ra phy screen ing in any way.
This was also the first mam mog ra phy screen ing
cam paign orig i nat ing from and car ried out on the soil
of Bosnia and Herzegovina it self. None the less, the
goals set and the way they were im ple mented, made
this a rather un typ i cal mam mog ra phy screen ing at -
tempt for nu mer ous rea sons, in clud ing the fol low ing
ones:
– lack of cen sus over the past 15 years, due to which
ex act data on the num ber of women aged  >40 (or 
>50) are un avail able,
– low er ing of the ini tial age lim its of the tar get
group down to 40 years of age; this step is jus ti fied 
by the ab sence of other types of sys tem atic breast
ex am i na tions and lack of med i cal in sur ance
among a large por tion of women be long ing to the
tar geted age group,
– omis sion of the dou ble-read ing pro ce dure for 
neg a tive mammographic find ings due to a se ri ous
lack of ad e quately qual i fied ra dio log i cal staff,
trained in com pli ance with mam mog ra phy
screen ing cri te ria, as well as the short age of equip -
ment (such as high-res o lu tion mam mog ra phy
workstations, com puter aided de tec tion (CAD)
soft ware or a cen tral ised softcopy/hardcopy
archive of mammographic im ages),
– non-sys tem atic, in dis crim i nate pub lic in for ma -
tion cam paign rel e vant to the mam mog ra phy
screen ing pro gram among the tar geted pop u la -
tion. Women were not called upon to take  an ex -
am i na tion from a sin gle da ta base, but by means of
pub lic calls and ad ver tise ments, or through family 
phy si cians, and
– absence of qual ity as sur ance (QA) and qual ity
con trol (QC) pro to cols for mam mog ra phy; only
re cently have the new reg u la tions on qual ity tests
and do sim e try in mam mog ra phy been re leased,
leav ing some un de fined ar eas in the de vel op ment
of screen ing-spe cific QA protocols.
A pe ri odic QC of all the X-ray units in the Re -
pub lic of Srpska has been re-es tab lished in the
post-war pe riod, more pre cisely, be tween 2001 and
2004 [5].
With the goal of pro vid ing an in sight in the pres -
ent tech ni cal as pects of the Re pub lic of Srpska mam -
mog ra phy screen ing pro gram, this pa per re views the
main types of mam mog ra phy equip ment cur rently in
use on its ter ri tory. Also, some re sults based on dose
mea sure ments (such as half-value layer, mean glan du -
lar dose and scat tered ra di a tion dose rates in prox im ity
of mammographic units) for stan dard breast ex am i na -
tion, are re ported here.
MA TE RI ALS AND METH ODS
X-ray units. In the frame work of the Re pub lic of
Srpska’s healthcare sys tem, 31 mam mog ra phy units (2 
of them be ing mo bile) of dif fer ent mod els and man u -
fac tur ers are cur rently in use, de ployed both in pub lic
and pri vate clin i cal in sti tutes, namely: Philips Fmax (1 
unit), Philips Mammo Diagnost (3), Planmed Sophie
(1), Metaltronica Lilyum (2), Siemens Mammomat
1000 (7), Siemens Mammomat 3000 (4), Siemens
Mammomat C3 (1), Hologic Lorad M-IV (1), GE
Performa (2), GE Al pha RT (2), GE Al pha ST (2), GE
Al pha III (2), GE Senographe 500T (2), and GE Med i -
cal Sys tems 800T (1). 
Im age re cep tors. Mam mog ra phy sys tems use
stan dard 18 cm × 24 cm, and 24 cm × 30 cm cas settes,
de pend ing on the size of the im aged breast. Var i ous
film-screen com bi na tions are used as im age re cep tors
in 30 out of 31 mam mog ra phy units. Films are pro -
cessed in non-ded i cated pro cess ing units which, it has
to be added, are not rou tinely tested. The only case of
in di rect dig i ta li za tion of mam mog ra phy is found at the 
De part ment of Ra di ol ogy of the Banja Luka Clin i cal
Cen tre where an anal o gous mammo unit is cou pled
with KO DAK 975 com puted ra di og ra phy reader, sup -
port ing both plain and mam mog ra phy cas settes. Af ter
be ing read and post-pro cessed, the dig i tal im age is
viewed on high res o lu tion BARCO mon i tors and
filmed if nec es sary. Film ing is per formed on a KO -
DAK DW6800 dry printer with an in stalled mam mog -
ra phy up grade.
Qual ity as sur ance and qual ity con trol. Mam -
mog ra phy is one of the most tech ni cally de mand ing
im ag ing pro ce dures, re quir ing par tic u lar at ten tion at
each step. Reg u la tory bod ies and in sti tu tions cer ti fied
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for qual ity au dits are im por tant el e ments in the suc -
cess ful im ple men ta tion of the mammographic di ag -
nos tic chain. In the Re pub lic of Srpska, the au tho rized
in sti tu tion for do sim e try mea sure ments of X-ray
equip ment is the Re pub lic of Srpska Pub lic Health In -
sti tute.  X-ray equip ment is checked in form of an ac -
cep tance test when the new piece of equip ment is in -
stalled. For the units al ready in use, QC tests are
per formed on an an nual ba sis, as well as af ter each ma -
jor main te nance ser vice.
The stan dard do sim e try pro to col in cludes the
con trol of li censed X-ray equip ment, equip ment pre -
mises, as well as of sur round ing spaces such as cloak -
rooms, wait ing rooms, etc. The fol low ing pa ram e ters
are mea sured:
– func tion al ity of power sup ply (re sis tance, volt age
fluc tu a tions) [6],
– elec tri cal safety (leak age cur rents, ground ing,
etc.),
– X-ray tube and gen er a tor pa ram e ters (such as ac -
cu racy of X-ray tube volt age, reproducibility of
X-ray tube volt age, lin ear ity of tube cur rent for
dif fer ent val ues of tube volt age; reproducibility
and lin ear ity of ra di a tion out put, half-value layer – 
HVL) [7, 8],
– in ci dent air kerma or ESAK for stan dard breast,
func tion ing of au to matic ex po sure con trol (AEC)
sys tem in terms of dose in di ca tion [9, 10], and
– scat tered ra di a tion dose rate for the pur pose of
work place mon i tor ing.
How ever, the func tion al ity of AEC con cern ing
the re sult ing im age qual ity, film pro ces sor and view -
ing en vi ron ment are still not sub ject to test ing and
mea sure ments. Mam mog ra phy ex am i na tions may
yield ex ces sive ra di a tion dose val ues un less ap pro pri -
ate steps for dose op ti mi sa tion are un der taken. While
ad just ing dose val ues to the low est rea son ably achiev -
able, at ten tion must be paid not to com pro mise the di -
ag nos tic qual ity of the im age [4, 10-15].
An im por tant mam mog ra phy dose in dex is given 
by the so called mean glan du lar dose (also re ferred to
as MGD or DG) [9, 10, 15]. Di rect mea sure ment of
MGD is not pos si ble; in stead, an es ti mate for the real
pa tient or stan dard poly-methil metacrilate (PMMA)
phan tom is made, based on the mea sured value of in ci -
dent air kerma on breast skin sur face, cor rected by ap -
pro pri ately cho sen con ver sion fac tors. As a sub sti tute
to the real breast, a 45 mm PMMA do sim e try phan tom
is used as the stan dard in dose mea sure ments [9, 15].
As sum ing that the val ues of con ver sion fac tors for the
given mam mog ra phy unit, as well as the char ac ter is -
tics of the im aged breast (such as breast size and com -
po si tion) are known, the mean glan du lar dose may be
com puted as fol lows [10, 11, 15]
MGD Kgcs=
where K is the air kerma at en trance sur face, g – rep re -
sents a fac tor ac count ing for 50% breast glandularity,
vary ing with dif fer ent HVL val ues, c – the cor rec tion
for the de vi a tion of the breast tis sue ex am ined from
50% glandularity, whereas s is an in di ca tion of dif fer -
ent tar get-fil ter com bi na tions. Ac cord ing to the Eu ro -
pean guide lines for qual ity as sur ance in breast can cer
Screen ing and Di ag no sis [10], the ref er ence vale for
MGD is 2.5 mGy. 
For each mam mog ra phy unit, 2 sets of mea sure -
ments were per formed. The first was a work place
mon i tor ing or dose rate mea sure ment by means of a
por ta ble in stru ment. The sec ond set of mea sure ments
con sisted in a se ries of QC tests of the mammograph it -
self, in clud ing X-ray tube pa ram e ters and dose-re lated 
quan ti ties (such as air kerma), us ing ap pro pri ate phan -
toms.  
Ra di a tion mea sure ment in stru ments used for
these checks were the Scintillator Probe 6150AD-b
(by Automess, Ger many) and Bar ra cuda (by RTI Elec -
tron ics, Swe den). A 45 mm PMMA block was ap plied
as do sim e try phan tom. 
MGD is com puted for typ i cal clin i cal val ues of
the  tube  volt age  (kVp),  prod uct of cur rent  and  time
(It) and tar get-fil ter com bi na tion. Among the 31 units
tested, X-ray tube volt age was found to have a con -
stant value for each sin gle unit rang ing be tween 24 kV
and 34 kV. The cur rent-time prod uct var ied be tween
20 mA and 160 mA, whereas ex po sure time took the
val ues up to a max i mum of 1.8 s. In X-ray tubes, a
Mo/Mo tar get-fil ter com bi na tion was em ployed (see
tab. 1). The fo cus-film dis tance dur ing im age ac qui si -
tion was the same (65 cm) for all the units.
RE SULTS
Half value layer. HVL val ues for the 31 units
mea sured are given in tab. 1. They vary be tween
0.33-0.65 mm Al, whereas only the val ues com prised
within the 0.36  ±  0.02 mm Al range may be con sid -
ered sat is fac tory, ac cord ing to [10]. 
Mean glan du lar dose to the stan dard breast. The 
MGD for all 31 units was com puted based on the mea -
sured val ues of in ci dent air kerma on the sur face of a
45 mm PMMA phan tom. Mean glan du lar dose val ues
lie within the 0.28-7.74 mGy range. In 21 cases (68%), 
MGD in fe rior to 2 mGy was found; the re main ing 6
units (19%) had their MGD val ues com prised be tween 
2 and 2.5 mGy (i. e. be tween the achiev able and the ac -
cept able value, as pre scribed by [10]), whereas in 4
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Ta ble 1. Val ues ob tained for the stan dard breast sim u lated 
with a 45 mm PMMA do sim e try phan tom; c, g, and s
val ues have been taken from [10]
min max mean SD median
Uo [kV] 24 34 29 2 28
It [mAs] 20 160 77 30 80
K [mGy] 1.4 24 7.8 5.1 6.6
HVL [mmAI] 0.32 0.65 0.38 0.08 0.36
MGD [mGy] 0.27 7.7 1.7 1.6 1.3
units (13%), the MGD mea sured more than 2.5 mGy
(fig. 1). 
Ambiental dose rate. Dose rate mea sure ments
show that for 24 out of 31 mam mog ra phy units, dose
rates do not ex ceed 0.10 µSv/h. In 3 cases, on the door
of the tech ni cian’s room, dose rates within 0.20-0.30
µSv/h were mea sured. More over, dose rates rang ing
be tween 0.13-0.60 µSv/h were mea sured be hind mo -
bile shields in 3 cases. In one of the two mo bile units,
the dose rate on the front side of the door reached 0.62
µSv/h.
DIS CUS SION AND CON CLU SIONS
In the Re pub lic of Srpska, a mam mog ra phy
screen ing prac tice has, at least de clar a tively, been ap -
plied in the past sev eral years. Nev er the less, a strong
be lief that a whole se ries of steps along the ex ist ing
mam mog ra phy screen ing chain need to be un der taken
in or der to im prove the screen ing pro ce dure and bring
it to the level of com pli ance with Eu ro pean  qual ity
stan dards and newly pro mul gated national regulative
is all present.
Qual ity con trol pro to cols ap ply to all of the com -
po nents of the screen ing pro cess – not only the staff in -
volved, but the equip ment used, as well as prac tices
and le gal re quire ments im ple mented. It is, there fore,
nec es sary to main tain the screen ing equip ment in
good tech ni cal con di tion, as well as to per form the pre -
scribed pe ri odic qual ity checks of – i. e. im age ac qui si -
tion, pro cess ing, view ing, ar chiv ing, and in ter pre ta -
tion – such as light boxes, dis plays, com puted
ra di og ra phy cas settes and read ers, film de vel op ing
sys tems, la ser print ers, as well as stereotactic bi opsy
units, etc.
Ac cord ing to the lat est ra di a tion pro tec tion reg u -
la tions, es tab lish ing in ter nal QA and QC pro to cols for
each sin gle mam mog ra phy unit in volved in screen ing
is a man da tory step in the screen ing pro cess. These
pro to cols should in clude com pre hen sive equip ment
checks per formed by a med i cal phys i cist once ev ery
six months, as well as a se ries of much more fre quent
mea sure ments to be per formed rou tinely by radiogra-
phers/ra di ol ogy en gi neers (A level mea sure ments)
and, oc ca sion ally, by a medical physicist (B level
measurements) [10]: 
– de ter mi na tion of the air-ab sorbed-dose at fo -
cus-breast skin dis tance,
– HVL mea sure ment,
– high volt age [kVp] ac cu racy and reproducibility
test,
– ac cu racy and reproducibility test for ex po sure
time [s],
– lin ear ity and reproducibility of tube cur rent [mA],
– au to matic ex po sure con trol (AEC) check,
– fo cus-film dis tance (FFD) in di ca tor check,
– X-ray fo cal spot check,
– com pres sion mech a nism con trol,
– film pro cess ing el e ments: dark room con di tions,
pro ces sor, film emul sion (for film-screen only),
– im age qual ity check (op ti cal den sity, thresh old
con trast vis i bil ity, res o lu tion, ho mo ge ne ity/ar ti -
facts; sensitometry (speed, con trast, fog), and
– view ing con di tions (light boxes for hardcopy or
dig i tal dis plays of softcopy im ages; im pact of am -
bi ent light on view ing of both of the im age types).
QA for dig i tal mam mog ra phy sys tems. Cur rent
trends in ra dio log i cal prac tice im pose the ac qui si tion
of full field mam mog ra phy units (FFDM) in the near -
est fu ture. Sub se quently, QC pro to cols for DR mam -
mog ra phy need to be in tro duced. Na tional leg is la tion
pre scribes the fol low ing FFDM spe cific tests, in ad di -
tion to the above mentioned quality checks:
– dig i tal im age re cep tor (re sponse func tion, X-ray
field align ment with the im age re cep tor’s edge at
chest wall side, de tec tor el e ment ho mo ge ne ity, de -
fec tive dels, etc.),
– mon i tors (geo met ri cal dis tor tion, con trast vis i bil -
ity, dis play artefacts, lu mi nance range, dis -
tance-an gle cal i bra tion, con trast res o lu tion, 
DICOM greyscale stan dard dis play func tion, uni -
for mity, etc.),
– dig i tal im age qual ity, and
– dry print ers.
QA pro to cols for com puted ra di og ra phy  sys -
tems are even more chal leng ing to es tab lish and im ple -
ment, as the com puted ra di og ra phy im ag ing chain
con sists of fol low ing com po nents: a mam mog ra phy
unit, com puted ra di og ra phy cas settes and reader, mon -
i tors and dry printer, usu ally pro vided by dif fer ent
man u fac tur ers. Aside from the in her ent prop er ties of
dig i tal sys tems (quan tum noise, de tec tor sen si tiv ity,
dif fer ent im age pro cess ing al go rithms, prob lems with
sys tem con fig u ra tion in case of power loss, etc.), there
are many other pa ram e ters that re quire fine tun ing,
both from im age qual ity and dose op ti mi sa tion point
of view (kVp com pen sa tion, etc.).
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Fig ure 1. Re sults of MGD as sess ment in
31 mam mog ra phy units
Based on the sta tis ti cal data pre sented in the
form of ta bles and plots, it can be con cluded that there
are large fluc tu a tions in MGD. Al though for the ma -
jor ity of units tested, the MGD was found to com ply
with ref er ence val ues, in sev eral cases, the le gally pre -
scribed lev els were sig nif i cantly ex ceeded. This sit u a -
tion calls for a se ries of cor rec tive mea sures, both on
the main te nance and im age ac qui si tion level.
Even among the mammographs whose pa ram e -
ters com ply with le gal re quire ments, there are sig nif i -
cant fluc tu a tions in mea sured val ues of the pa ram e ters
con sid ered in this pa per, which is un ac cept able ac cord -
ing to mam mog ra phy screen ing qual ity cri te ria. It is,
there fore, nec es sary to har mo nize all pa ram e ters rel e -
vant to mammo im ag ing in all healthcare in sti tu tions
ap pointed for the im ple men ta tion of mam mog ra phy
screen ing.
Es tab lish ing a fully in te grated QA and QC sys -
tem is a joint task of all the par tic i pants in the mam -
mog ra phy screen ing chain [10]. 
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FIZI^KO-TEHNI^KI  ASPEKTI  KONTROLE  KVALITETA  U
MAMOGRAFIJI  U  REPUBLICI  SRPSKOJ
Rak dojke je naj~e{}e maligna neoplazma u `enskoj populaciji. Sa ciqem da se smawi
morbiditet i mortalitet od raka dojke, u oba entiteta Bosne i Hercegovine organizovane su
kampawe skrining mamografije. U ovom radu dat je kratak prikaz skrining mamografije u
Republici Srpskoj. Kao ilustracija trenutnog stawa tehni~kih parametara, navode se sredwe
vrednosti debqine poluslabqewa i vr{i se prora~un  sredwe glandularne doze za 31 mamograf, na
osnovu rezultata merewa koje je izvr{ila za to sertifikovana institucija. Uo~qive su velike
fluktuacije u vrednostima doze izme|u pojedina~nih aparata obuhva}enih merewem, {to je
nedopustivo ne samo u svetlu skrining mamografije nego i u klini~koj mamografiji. Zbog toga se
predla`e niz testova kvaliteta i korektivnih mera koje bi trebalo da obuhvate ~itav
dijagnosti~ki proces, u skladu sa evropskim smernicima i nedavno usvojenim nacionalnim
pravilnicima. Optimizacija doza i poboq{awe kvaliteta dijagnosti~ke slike predstavqaju prvi
i najva`niji uslov uspostavqawa uspe{nog programa skrining mamografije.
Kqu~ne re~i: skrining mamografija, kontrola kvaliteta, sredwa glandularna doza
